Hemophilia without prophylaxis: Assessment of joint range of

Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations?, Thrombosis Journal

Hemophilia A and B: An Overview

Efficacy in Adults & Adolescents

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies - ScienceDirect

Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study - Matino - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Functional Independence Score in Hemophilia (FISH) - eLearning Platform

A Molecular Revolution in the Treatment of Hemophilia: Molecular Therapy

Algorithm for management of emergency situations in patients with

Assessment of Joint Health and Outcome Measures in Hemophilia

Assess joint health, Hemophilia Treatment

Early FVIII Prophylaxis Improves Long-Term Joint Outcomes in Severe Hemophilia A

Treatment of hemophilia: a review of current advances and ongoing issues. - Abstract - Europe PMC

Advances in Hemophilia A Management - Advances in Pediatrics

PDF) Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity

Hemophilia Review